Free Trial

HST Global Q4 2022 Earnings Report

$0.85 0.00 (0.00%)
(As of 12/20/2024 ET)

HST Global EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

HST Global Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

HST Global Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.

HST Global Earnings Headlines

HST Global Inc HSTC
2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis
Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.
Vinaconex Investment and Tourism Development JSC
See More HST Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like HST Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on HST Global and other key companies, straight to your email.

About HST Global

HST Global (OTCMKTS:HSTC), operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.

View HST Global Profile

More Earnings Resources from MarketBeat

Upcoming Earnings